Cargando…
Perioperative Targeted Therapy Or Immunotherapy In Non-Small-Cell Lung Cancer
Targeted therapy and immunotherapy have changed the treatment modes for advanced non-small cell lung cancer (NSCLC), moving from second-line to first-line treatment and significantly extending patients’ survival. Surgery and chemoradiotherapy remain the main treatment options for patients with local...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781597/ https://www.ncbi.nlm.nih.gov/pubmed/31632066 http://dx.doi.org/10.2147/OTT.S222412 |
_version_ | 1783457401548046336 |
---|---|
author | Sa, Huanlan Song, Peng Ma, Kewei Gao, Yong Zhang, Li Wang, Deqiang |
author_facet | Sa, Huanlan Song, Peng Ma, Kewei Gao, Yong Zhang, Li Wang, Deqiang |
author_sort | Sa, Huanlan |
collection | PubMed |
description | Targeted therapy and immunotherapy have changed the treatment modes for advanced non-small cell lung cancer (NSCLC), moving from second-line to first-line treatment and significantly extending patients’ survival. Surgery and chemoradiotherapy remain the main treatment options for patients with locally advanced lung cancer, but recurrence and metastasis still occur in some patients. The survival rates of conventional perioperative chemotherapy among NSCLC patients have increased by only 5%. Therefore, more studies have begun to explore targeted and immune neoadjuvant/adjuvant therapies in early-stage and locally advanced NSCLC, and the relevant clinical research data have shown good efficacy and safety profiles. This article summarizes several clinical studies of critical importance. |
format | Online Article Text |
id | pubmed-6781597 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-67815972019-10-18 Perioperative Targeted Therapy Or Immunotherapy In Non-Small-Cell Lung Cancer Sa, Huanlan Song, Peng Ma, Kewei Gao, Yong Zhang, Li Wang, Deqiang Onco Targets Ther Review Targeted therapy and immunotherapy have changed the treatment modes for advanced non-small cell lung cancer (NSCLC), moving from second-line to first-line treatment and significantly extending patients’ survival. Surgery and chemoradiotherapy remain the main treatment options for patients with locally advanced lung cancer, but recurrence and metastasis still occur in some patients. The survival rates of conventional perioperative chemotherapy among NSCLC patients have increased by only 5%. Therefore, more studies have begun to explore targeted and immune neoadjuvant/adjuvant therapies in early-stage and locally advanced NSCLC, and the relevant clinical research data have shown good efficacy and safety profiles. This article summarizes several clinical studies of critical importance. Dove 2019-10-03 /pmc/articles/PMC6781597/ /pubmed/31632066 http://dx.doi.org/10.2147/OTT.S222412 Text en © 2019 Sa et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Sa, Huanlan Song, Peng Ma, Kewei Gao, Yong Zhang, Li Wang, Deqiang Perioperative Targeted Therapy Or Immunotherapy In Non-Small-Cell Lung Cancer |
title | Perioperative Targeted Therapy Or Immunotherapy In Non-Small-Cell Lung Cancer |
title_full | Perioperative Targeted Therapy Or Immunotherapy In Non-Small-Cell Lung Cancer |
title_fullStr | Perioperative Targeted Therapy Or Immunotherapy In Non-Small-Cell Lung Cancer |
title_full_unstemmed | Perioperative Targeted Therapy Or Immunotherapy In Non-Small-Cell Lung Cancer |
title_short | Perioperative Targeted Therapy Or Immunotherapy In Non-Small-Cell Lung Cancer |
title_sort | perioperative targeted therapy or immunotherapy in non-small-cell lung cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781597/ https://www.ncbi.nlm.nih.gov/pubmed/31632066 http://dx.doi.org/10.2147/OTT.S222412 |
work_keys_str_mv | AT sahuanlan perioperativetargetedtherapyorimmunotherapyinnonsmallcelllungcancer AT songpeng perioperativetargetedtherapyorimmunotherapyinnonsmallcelllungcancer AT makewei perioperativetargetedtherapyorimmunotherapyinnonsmallcelllungcancer AT gaoyong perioperativetargetedtherapyorimmunotherapyinnonsmallcelllungcancer AT zhangli perioperativetargetedtherapyorimmunotherapyinnonsmallcelllungcancer AT wangdeqiang perioperativetargetedtherapyorimmunotherapyinnonsmallcelllungcancer |